Open AccessOccurrence of DEA1.1 in blood donor dogs in Cuiabá, Mato Grosso, Brazil
Author(s) -
Mariana Elisa Pereira,
Marcela Natacha Aparecida Rocha,
Adriane Jorge Mendonça,
Arleana do Bom Parto Ferreira de Almeida,
Darlan Henrique Canei,
Valéria Régia Franco Sousa
Publication year - 2020
Publication title -
semina. ciências agrárias
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.268
H-Index - 25
eISSN - 1679-0359
pISSN - 1676-546X
DOI - 10.5433/1679-0359.2020v41n3p1067
Subject(s) - purebred , vacutainer , agglutination (biology) , breed , veterinary medicine , population , direct agglutination test , blood donor , medicine , antigen , antibody , biology , zoology , immunology , serology , environmental health
This study aimed to assess Dog Erythrocyte Antigen (DEA) 1.1 in donor dogs at the Federal University of Mato Grosso, Cuiabá, Brazil, and review the relevant literature. The blood (60 samples; 1.5 mL volume, each) was collected in separate vacutainer tubes containing ethylenediaminetetraacetic acid and submitted for complete blood count; in addition, the samples were typed by RapidVet® based on agglutination due to specific interaction between DEA 1 antigen at the membrane surface of the erythrocyte and lyophilised murine monoclonal antibody on the test card. DEA1.1 positivity was observed in 81.6% (49 of 60) of test samples, while negative results were obtained in the remaining 18.3% (11 of 60). DEA 1.1 positive samples were comprised of 42.8% of purebred dogs and 38.3% of mixed breed dogs. With regard to sex in the DEA 1.1 positive group, 48.3% were male dogs and 33.3% were female dogs. The blood donor canine population showed high prevalence of DEA 1.1, which confirms that blood typing should be performed prior to blood transfusion in previously sensitised dogs.